Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IPILIMUMAB vs IRBESARTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IPILIMUMAB vs IRBESARTAN: Safety Overview

Metric IPILIMUMAB IRBESARTAN
Total FAERS Reports 36,528 10,144
Deaths Reported 8,043 636
Death Rate 22.0% 6.3%
Hospitalizations 17,031 5,374
Average Patient Age 62.9 yrs 69.0 yrs
% Female Patients 35.4% 60.2%
FDA Approval Date N/A Apr 17, 2018
Manufacturer E.R. Squibb & Sons, L.L.C. Bryant Ranch Prepack
Route INTRAVENOUS ORAL
Marketing Status Prescription Discontinued